134 related articles for article (PubMed ID: 29344246)
1. Silibinin inhibits migration and invasion of the rhabdoid tumor G401 cell line via inactivation of the PI3K/Akt signaling pathway.
Li Y; Zhang C; Cai D; Chen C; Mu D
Oncol Lett; 2017 Dec; 14(6):8035-8041. PubMed ID: 29344246
[TBL] [Abstract][Full Text] [Related]
2. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
Qu Q; He Z; Jiang Y; Lu D; Long X; Ding Y; Xu B; He X
Med Sci Monit; 2019 Oct; 25():7527-7537. PubMed ID: 31589596
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
4. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
[TBL] [Abstract][Full Text] [Related]
5. BKM120 inhibits malignant rhabdoid tumor of the kidney through induction of apoptosis and G0/G1 phase arrest.
Liu J; Mi T; Zhang Z; Jin L; Li M; Zhanghuang C; Li M; Wang J; Wu X; Wang Z; Tan X; Wang Z; He D
Eur J Pharmacol; 2023 Jul; 951():175747. PubMed ID: 37142086
[TBL] [Abstract][Full Text] [Related]
6. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone A inhibits cell proliferation, migration, and invasion through regulating the PI3K/AKT signaling pathway in oral squamous cell carcinoma.
Hao Y; Zhang C; Sun Y; Xu H
Onco Targets Ther; 2019; 12():4427-4435. PubMed ID: 31239711
[No Abstract] [Full Text] [Related]
8. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line.
Wang Y; Yuan J; Yang L; Wang P; Wang X; Wu Y; Chen K; Ma R; Zhong Y; Guo X; Gong Y; Gui M; Jin Y
Adv Clin Exp Med; 2018 Jul; 27(7):899-905. PubMed ID: 29790698
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline hydrochloride inhibits the progress of malignant rhabdoid tumor of kidney by targeting MMP17 and MMP1 through PI3K-Akt signaling pathway.
Mi T; Zhang Z; Zhanghuang C; Jin L; Tan X; Liu J; Wu X; Li M; Wang J; Wang Z; Guo P; He D
Eur J Pharmacol; 2024 Feb; 964():176291. PubMed ID: 38158115
[TBL] [Abstract][Full Text] [Related]
11. Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
Li F; Sun Y; Jia J; Yang C; Tang X; Jin B; Wang K; Guo P; Ma Z; Chen Y; Wang X; Chang L; He D; Zeng J
Oncol Rep; 2018 Dec; 40(6):3543-3550. PubMed ID: 30272315
[TBL] [Abstract][Full Text] [Related]
12. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
[TBL] [Abstract][Full Text] [Related]
13. Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway.
Lu S; Zhang Z; Chen M; Li C; Liu L; Li Y
Oncol Lett; 2017 Dec; 14(6):7577-7582. PubMed ID: 29344204
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Zhao L; Zhang J; Fan Y; Li Y
Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
[TBL] [Abstract][Full Text] [Related]
15. [microRNA-16-5p targeted tetraspanin 15 gene to inhibit the proliferation, migration and invasion of osteosarcoma cell through phospoinositide 3-kinase/protein kinase B signaling pathway].
Yu JB; Zhang HJ; Yan LW; Chang F; Jia ZW; Yang XR
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1668-1675. PubMed ID: 32486604
[No Abstract] [Full Text] [Related]
16. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.
Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ
Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
18. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways.
Chen PN; Hsieh YS; Chiou HL; Chu SC
Chem Biol Interact; 2005 Oct; 156(2-3):141-50. PubMed ID: 16169542
[TBL] [Abstract][Full Text] [Related]
19. Compound Wumei Powder Inhibits the Invasion and Metastasis of Gastric Cancer via Cox-2/PGE2-PI3K/AKT/GSK3
Ma NX; Sun W; Wu J; Liu SL; Weng L; Liu YQ; Pu WX; Wu TT; Ding XL; Huang NG; Zheng PQ; Zou X
Evid Based Complement Alternat Med; 2017; 2017():3039450. PubMed ID: 29358963
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
